ABSTRACT
Glomerular matrix accumulation is the hallmark of diabetic nephropathy. The metalloprotease ADAM17 mediates high glucose (HG)-induced matrix production by kidney mesangial cells through release of ligands for the epidermal growth factor receptor. Here, we study the mechanism by which HG activates ADAM17. We find that the C-terminus is essential for ADAM17 activation and the profibrotic response to HG. In the C-terminus, Src-mediated Y702 phosphorylation and PI3K–MEK–Erk-mediated T735 phosphorylation are crucial for ADAM17 activation, both are also required for the HG-induced increase in cell surface mature ADAM17. The non-receptor tyrosine kinase FAK is a central mediator of these processes. These data not only support a crucial role for the C-terminus in ADAM17 activation and downstream profibrotic responses to HG, but also highlight FAK as a potential alternative therapeutic target for diabetic nephropathy.
Footnotes
Competing interests
The authors declare no competing or financial interests.
Author contributions
Conceptualization: J.C.K.; Methodology: R.L.; Formal analysis: J.C.K.; Data curation: R.L., T.W., K.W., B.G.; Writing - original draft: J.C.K.; Writing - review & editing: J.C.K.; Supervision: J.C.K.; Project administration: J.C.K.
Funding
This work was supported by the Institute of Nutrition, Metabolism and Diabetes of the Canadian Institutes of Health Research (CIHR) (MOP119308 to J.C.K.).
Supplementary information
Supplementary information available online at http://jcs.biologists.org/lookup/doi/10.1242/jcs.208629.supplemental
- Received July 17, 2017.
- Accepted December 28, 2017.
- © 2018. Published by The Company of Biologists Ltd
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Subject collections
Other journals from The Company of Biologists
JCS and COVID-19
For more information on measures Journal of Cell Science is taking to support the community during the COVID-19 pandemic, please see here.
If you have any questions or concerns, please do not hestiate to contact the Editorial Office.
The Company of Biologists commits to the Transformative Journal approach
The Company of Biologists is the first not-for-profit publisher to commit to this approach. The Company’s three hybrid journals - Development, Journal of Cell Science and Journal of Experimental Biology - have chosen the ‘transformative’ route towards Open Access. Find out more in this interview with Claire Moulton, Publisher at The Company of Biologists and on our dedicated Transformative Journals page.
Extended deadline - Special Issue on Cell Biology of Host-Pathogen Interactions
We have extended the deadline for submissions for our next special issue, which will be guest-edited by Derek Walsh (Northwestern University, USA). Submission deadline is now 15 September 2020 - find out more.
The Corona Files
“Most of the scientists I know are frogs, by which I mean, they will happily lend a hand to their colleagues if their expertise would be helpful in solving an interesting problem.”
Our resident insectivore, Mole, continues his latest series – The Corona Files. Catch up on Mole’s weekly musings on how COVID-19 is changing the landscape for researchers.
Science and art – the not so odd couple?
Over on FocalPlane, Sophie Morgani discusses the somewhat surprising relationship between science and art.
First person interview - Eryn Dixon
Eryn Dixon is first author of a new Tools & Resources paper that presents a new model system that generates kidney tubule-like structures in a dish. Find out more about Eryn and her research in an interview.